Medartis
Medartis AG, headquartered in Switzerland (CH), is a leading player in the medical device industry, specialising in innovative solutions for the treatment of bone fractures and deformities. Founded in 1997, the company has established a strong presence in Europe, Asia, and the Americas, focusing on advanced surgical techniques and high-quality implants. Medartis is renowned for its unique product offerings, including the patented locking plate systems and comprehensive range of surgical instruments designed for orthopaedic and trauma surgery. These products are distinguished by their precision engineering and commitment to enhancing patient outcomes. With a solid market position, Medartis has achieved significant milestones, including numerous regulatory approvals and partnerships with healthcare professionals worldwide, solidifying its reputation as a trusted provider in the orthopaedic sector.
DitchCarbon Score
How does Medartis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medartis's score of 36 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medartis's reported carbon emissions
In 2023, Medartis reported total carbon emissions of approximately 6,857,000 kg CO2e. This figure includes 857,000 kg CO2e from Scope 1 emissions, primarily from stationary combustion, and 604,000 kg CO2e from Scope 2 emissions, mainly from purchased electricity. The company also disclosed significant Scope 3 emissions, totalling about 5,396,000 kg CO2e, which encompass various categories such as business travel (571,000 kg CO2e) and purchased goods and services (2,498,000 kg CO2e). In comparison, Medartis's 2022 emissions were approximately 1,626,000 kg CO2e for Scope 1 and 2 combined, indicating a substantial increase in emissions in 2023. The company has committed to near-term climate targets, although specific reduction targets have not been detailed. Medartis is actively engaged in climate initiatives within the healthcare equipment and supplies sector, reflecting its commitment to sustainability and environmental responsibility. Headquartered in Switzerland, Medartis continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 795,000 | 000,000 |
| Scope 2 | 831,000 | 000,000 |
| Scope 3 | 689,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medartis is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
